Here are relevant reports on : pcr-thermocycler-market
-
Companion Animal Diagnostic Market by Product (Consumable, Instrument), Technology (Immunodiagnostic, ELISA, PCR Test, Urinalysis, Hematology), Animal Type (Dog, Cat), Application (Clinical Pathology, Virology), End User - Global Forecast to 2031
The global Companion Animal Diagnostic market, valued at USD 3.29 billion in 2025, stood at USD 3.56 billion in 2026 and is projected to advance at a resilient CAGR of 8.7% from 2026 to 2031, culminating in a forecasted valuation of USD 5.40 billion by the end of the period. Factors driving the companion animal diagnostics market include the rising demand for rapid and accurate diagnostic testing, the rising use of advanced technologies such as molecular diagnostic tests and AI-based analyzers, and also the growing focus on preventive and early diagnostic testing for companion animals.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
US Veterinary Diagnostics Market by Application (Infectious, Bacterial, Endocrine), Technology (Immunodiagnostic, PCR, ELISA, Lateral Flow), Product (Consumables, Instruments), Animal Type (Dog, Cat, Cattle), End User (POC, Veterinary Labs) – Forecast to 2031
The US veterinary diagnostics market, valued at USD2.22 billion in 2025, stood at USD2.41 billion in 2026 and is projected to advance at a resilient CAGR of 9.1% from 2026 to 2031, culminating in a forecasted valuation of USD3.74 billion by the end of the period.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Minimal Residual Disease Market by Product (Kits, Instruments), Technology (PCR, NGS), Application (Leukemia, Lymphoma, Multiple Myeloma, Solid Tumors), End User (Hospitals, Diagnostic Labs, Research Institutes), & Region - Global Forecast to 2029
The global minimal residual disease testing market, valued at US$1.27 billion in 2023, stood at US$1.43 billion in 2024 and is projected to advance at a resilient CAGR of 12.2% from 2024 to 2029, culminating in a forecasted valuation of US$2.55 billion by the end of the period. The market is driven by the growing prevalence of cancer globally and increasing funding from international organizations and governments for cancer prevention programs.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
DNA Diagnostics Market by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Global Forecast to 2029
The global DNA diagnostics market, valued at US$12.3 billion in 2023, stood at US$13.3 billion in 2024 and is projected to advance at a resilient CAGR of 9.7% from 2024 to 2029, culminating in a forecasted valuation of US$21.2 billion by the end of the period. Growth in the market is primarily driven by the technological improvements in the DNA diagnostics industry and the growing need for personalized treatment and early disease diagnosis in developing nations. Also, the increased investments by healthcare-based companies are majorly contributing to growth of the market.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Malaria Diagnostic Market by Technology (Rapid Diagnostic Test, PCR, Microscopy, ELISA, Isothermal Nucleic Acid Amplification), End User (Hospital & Diagnostic Laboratories, Blood Bank, Research Institute/Academics, Home care center) - Global Forecast to 2023
Rising prevalence of malaria in developing countries, increasing demand of molecular based diagnostics test and increasing funding and government support towards developing diagnostic kits are some of the factors driving the growth of the malaria diagnostics market. On the other hand, high expense involved in R&D activities is one of the major factors restraining the growth of this market. Whereas emerging markets are expected to provide significant growth opportunities in this market.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
High-Resolution Melting Analysis Market by Product (Supermix Reagent, RT PCR Instrument, Software), Application (SNP Genotyping, Mutation Discovery, Epigenetics), Enduser (Research Laboratories, Hospital, Diagnostic Center) - Global Forecast to 2021
The global high-resolution melting analysis market is projected to grow at a CAGR of 3.1%. Rising prevalence of infectious diseases and genetic disorders; increasing public-private investments, funds, and grants for research on genetic analysis technologies; and advantages of HRM over other genotyping technologies are the major factors driving market growth.
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030
The global veterinary infectious disease diagnostics market, valued at US$2.66 billion in 2024, stood at US$2.87 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$4.22 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious, Neurological), Application (Diagnostic, Research) - Global Forecast to 2030
The global biomarkers market, valued at USD 58.07 billion in 2024, stood at USD 62.39 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of USD 104.15 billion by the end of the period. This growth is supported by the growing use of biomarkers in drug development and the increasing role of companion diagnostics in advancing precision medicine.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Epigenetics Market by Product & Service (Enzymes, Kits & Reagents (Antibodies), Software), Method (DNA Methylation, Histone Modification), Technique (NGS, PCR), Application (Oncology, Immunology, Developmental Biology), End User - Global Forecast to 2030
The global epigenetics market, valued at USD 2.03 billion in 2024, stood at USD 2.24 billion in 2025 and is projected to advance at a resilient CAGR of 13.9% from 2025 to 2030, culminating in a forecasted valuation of USD 4.29 billion by the end of the period. The major factors driving the growth in epigenetics market includes reduced sequencing costs and accelerated turnaround times to improve access and affordability of epigenetic analysis.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) - Global Forecast to 2030
The global genomics market, valued at US$44.52 billion in 2024, stood at US$47.07 billion in 2025 and is projected to advance at a resilient CAGR of 12.6% from 2024 to 2030, culminating in a forecasted valuation of US$85.09 billion by the end of the period. The growth of the genomics market is driven by increasing government funding for genomics projects, a rising prevalence of viral and inherited disorders, advancements in NGS platforms, and the expansion of applications in genomics.
- Published: November 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
